Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 4Observational 1

Sponsor

Conditions

Breast Neoplasms 3Urinary Bladder Neoplasms 2Sarcoma 2Prostatic Neoplasms 2Pancreatic Cyst 2Neoplasms 2Melanoma 2Stomach Neoplasms 1Stage IB Cervical Cancer FIGO 2018 1Spondylitis, Ankylosing 1Psoriasis 1Papillomavirus Infections 1Pancreatic Neoplasms 1Pancreatic Diseases 1Ovarian Neoplasms 1Neoplasm Metastasis 1Lupus Erythematosus, Systemic 1Kidney Neoplasms 1Inflammatory Bowel Diseases 1Hepatitis B, Chronic 1Giant Cell Tumor of Bone 1Crohn Disease 1Colitis, Ulcerative 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Bone Neoplasms 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Arthritis, Reactive 1

Interventions

Data Collection 9human papillomavirus vaccine, L1 type 16, 18 4Blood Specimen Collection 4Surveys and Questionnaires 3Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3Specimen Handling 2Polymerase Chain Reaction 2Papillomavirus Vaccines 2Observation 2Colposcopy 2Viral Load 1Vaginal Smears 1Vaccination 1Restraint, Physical 1Papanicolaou Test 1Methods 1Mass Screening 1Liquid Biopsy 1Interviews as Topic 1Independent Medical Evaluation 1Human Papillomavirus Recombinant Vaccine nonavalent 1Human Papillomavirus DNA Tests 1Histological Techniques 1High-Energy Shock Waves 1Gene Expression Profiling 1Focus Groups 1Flow Cytometry 1Early Intervention, Educational 1Cytological Techniques 1Cryotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Papillomavirus Infections × Methods × Clear all
NCT04528407 2025-02-13

BS-FU01 Follow-Up Study of FluBHPVE6E7 Study Subjects

BlueSky Immunotherapies GmbH

Completed
25 enrolled

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡